Clinical Research
Ananda Exits Landmark NHS-Funded Epilepsy Trial and Public Markets
Ananda Pharma, one of the UK’s leading clinical-stage pharmaceutical cannabis companies, has announced a string of strategic pivots, including stepping away from a flagship UK clinical trial into epilepsy.